Invention Grant
- Patent Title: Heterocyclic compounds and uses as anticancer agents
-
Application No.: US13740182Application Date: 2013-01-12
-
Publication No.: US10799504B2Publication Date: 2020-10-13
- Inventor: Xiao Xu , Xiaobo Wang , Long Mao , Li Zhao , Biao Xi
- Applicant: ACEA BIOSCIENCES INC.
- Applicant Address: US CA San Diego
- Assignee: ACEA THERAPEUTICS, INC.
- Current Assignee: ACEA THERAPEUTICS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Rimon, P.C.
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D401/14 ; C07D403/12 ; A61K45/06 ; C07D239/42 ; C07D401/12 ; A61K31/519 ; A61K31/52 ; C07D473/32 ; C07D487/04 ; C07D473/34 ; C07D239/48 ; C07D473/24 ; C07D239/46 ; C07D473/40 ; C07D487/02 ; C07D473/16 ; C07D239/47
Abstract:
The present disclosure provides pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment of tumors and related diseases related to the dysregulation of kinase (such as EGFR (including HER), Alk, PDGFR, but not limited to) pathways.
Public/Granted literature
- US20130190320A1 HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS Public/Granted day:2013-07-25
Information query
IPC分类:
